Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a pioneer in metabolically healthy weight loss, today announced it has passed critical milestones in the U.S. Food and Drug ...

This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...

Trifecta Health and Trifecta Med Spa are excited to announce two strategic cooperations aimed at improving patient access to high-quality obesity treatments. These cooperations will streamline the ...

Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.

The Combating Counterfeit Pharmaceuticals Act, which would amend the Fentanyl Sanctions Act, is authored by Sens. Tom Cotton ...

Alabama Attorney General Steve Marshall says that a Cullman County Circuit Court approved his request for a temporary ...

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label, the FDA ...

Meghan Trainor shows off stunning weight loss transformation at Baby2Baby Gala in ivory ballgown, eight months after ...

Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...

Below, doctors explain everything you need to know about the phenomenon. It’s important to be clear upfront that “Ozempic ...

Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted in a FOX Business appearance.

The announcement comes on the heels of a deal with the Trump administration to expand access to weight-loss drugs and reduce ...